Tag Archives: Antibody Drug Conjugates Market

Could a single therapy revolutionize cancer treatment while reducing side effects? That’s the promise driving the Antibody Drug Conjugates (ADC) Market. These innovative therapies combine the targeting ability of antibodies with the cancer-killing power of cytotoxic drugs. But what makes them so compelling, and why are they rapidly gaining attention in the pharmaceutical world? WhyContinue reading “Why Is the Antibody Drug Conjugates Market Rising Fast?”